Unit:
|
Taiwan Affairs Office of Fuzhou Municipal People’s Government
|
![]() |
Project Area:
|
Fuzhou Cross-Strait Biotech Health Care Demonstration Zone
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Collaborate
|
|
Nature of Project:
|
Encourage
|
|
Working Progress in Prior Period:
|
none
|
|
Total Investment:
|
discussed in detai
|
|
Expected to Attract Investment:
|
discussed in detai
|
|
Benefit Analysis:
|
none
|
|
Reason and Condition:
|
none
|
|
Content and Scale:
|
It intends to introduce a group of top 100 competitive enterprises in Taiwan and high-end industrial talents, to fully leverage the market demand and technological advantages of medical services in both Fujian and Taiwan. The project focuses on developing medical services including smart medical care, precision medicine, and regenerative medicine treatment, health care services including elderly and health management, and standardized care, and innovative, application-led, and complementary cell gene therapy and new demonstration bases, and achieve the goal of "aging well and slowly".
|
|
Others:
|
none
|
Biological & New Pharmaceutical Industry
In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.